406 related articles for article (PubMed ID: 16531088)
1. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
2. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
Depondt C; Shorvon SD
Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
[TBL] [Abstract][Full Text] [Related]
3. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
4. Current challenges in the treatment of epilepsy.
Mattson RH
Neurology; 1994 Jun; 44(6 Suppl 5):S4-9; discussion S31-2. PubMed ID: 8022538
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
Depondt C
Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN; Buono RJ
Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
[TBL] [Abstract][Full Text] [Related]
7. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
Herranz JL
Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
[TBL] [Abstract][Full Text] [Related]
10. Monotherapy clinical trial design.
Sachdeo R
Neurology; 2007 Dec; 69(24 Suppl 3):S23-7. PubMed ID: 18071154
[TBL] [Abstract][Full Text] [Related]
11. Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.
Ferraro TN; Dlugos DJ; Buono RJ
Pharmacogenomics; 2006 Jan; 7(1):89-103. PubMed ID: 16354127
[TBL] [Abstract][Full Text] [Related]
12. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.
Löscher W; Schmidt D
Epilepsia; 2011 Apr; 52(4):657-78. PubMed ID: 21426333
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
Schmidt D; Löscher W
Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
[TBL] [Abstract][Full Text] [Related]
14. [Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions].
Falip M; Artazcoz L; de la Peña P; Pérez-Sempere A; Martín-Moro M; Codina M;
Neurologia; 2005 Mar; 20(2):71-6. PubMed ID: 15726473
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of epilepsy: new armamentarium, new issues.
Vajda FJ
J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
[TBL] [Abstract][Full Text] [Related]
16. Update on pharmacogenetics in epilepsy: a brief review.
Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
[TBL] [Abstract][Full Text] [Related]
17. Prospects for novel antiepileptic drugs.
Avanzini G; Franceschetti S
Curr Opin Investig Drugs; 2003 Jul; 4(7):805-14. PubMed ID: 14619401
[TBL] [Abstract][Full Text] [Related]
18. Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs.
Perucca E
Epileptic Disord; 2005 Sep; 7 Suppl 1():S14-21. PubMed ID: 16120489
[TBL] [Abstract][Full Text] [Related]
19. Response to antiepileptic drug therapy: winners and losers.
Brodie MJ
Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
